Facebook Linkedin Twitter
Inside Precision Medicine Invitae, BioMarin Expand Screening Program for Genetic Epilepsy

Therapeutics

EEG with electrical activity of abnormal brain in epilepsy electroencephalogram,EEG
Molecular Dx

Invitae, BioMarin Expand Screening Program for Genetic Epilepsy

0
Killer T-lymphocyte attacking a cancer cell
News & Features

Immune-Enhanced Organoids Could Provide Immunotherapy Screening Platform

0
Dendritic cell and T-lymphocytes, illustration
Molecular Dx

Johns Hopkins Researchers Refine TMB Calculations of Immunotherapy Response

0
Genetic testing concept, DNA icon, medical doctor, isolated on white. Illustrating RNA sequencing to diagnose rare diseases
Molecular Dx

ArcherDX’s Personalized Cancer Monitoring (PCM) Tech Gets FDA Breakthrough Device Designation

0
pancreatic cancer cells
News & Features

Genomic Analysis Reveals New Pancreatic Cancer Subtypes

0
23andMe has raised an additional $250 million in growth financing
News & Features

23andMe Inks Monoclonal Antibody Deal for Inflammatory Disease Therapeutic Development

0
ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics
Molecular Dx

ArcherDx and Illumina to Partner, Co-Market In Vitro Diagnostics

0
Sea of US 1 dollar bills on yellow background
Molecular Dx

IsoPlexis’ $20M Financing to Enable Continued Commercial Expansion of its Single-Cell Platforms

0
2019: A Watershed Year for Genomics in Clinical Care
News & Features

2019: A Watershed Year for Genomics in Clinical Care

0
Lymphoma cancer cell that can be targeted by CAR T-cell therapy
News & Features

Protein Inhibitor Could be New Approach for Treating Non-Hodgkin Lymphomas

0
1...133134135...161Page 134 of 161

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine